Aytu BioScience Inc. (AYTU)

[stockvaper]

Healight has an enormous potential.

"Mr. Disbrow stated. “With such a broad set of potential clinical applications, we envision Healight, if successful, to become an important tool in hospital ICUs around the world. Antimicrobial resistance is a global problem and attacking it in a nontraditional way may prove to be a better way to treat difficult infections and rely less on traditional antibiotic and antiviral therapy.”

Antimicrobial resistance: a global multifaceted phenomenon

"The US Center for Disease Control and Prevention (CDC) conservatively estimated that, in the US, more than two million people every year are affected with antibiotic-resistant infections, with at least 23?000 dying as a result of the infection.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768623/